PLASMALOGEN PHOSPHOLIPIDS AS POTENTIAL PROTECTORS AGAINST LIPID-PEROXIDATION OF LOW-DENSITY LIPOPROTEINS

被引:108
作者
ENGELMANN, B [1 ]
BRAUTIGAM, C [1 ]
THIERY, J [1 ]
机构
[1] UNIV MUNICH,INST KLIN CHEM,MUNICH,GERMANY
关键词
D O I
10.1006/bbrc.1994.2595
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A phospholipid subgroup with potential antioxidant properties, the plasmalogen (1-alkenyl, 2-acyl-) fraction, was determined to constitute about 4.5% of total LDL phospholipids. In vitro oxidation of LDL by 2,2'-azobis-(2-amidinopropane hydrochloride) (AAPH, 0.5-10mM) or 5 mu M copper induced a selective reduction of plasmalogen subgroups in phosphatidylcholine and phosphatidylethanolamine by 15%-35% within 30 min. Under the same experimental conditions alpha tocopherol (vitamin E) levels were lowered by 5%-40%, indicating a comparable sensitivity of plasmalogen phospholipids and alpha tocopherol towards oxidative attack by AAPH and copper. In vitro enrichment of LDL with l-alkenyl, 2-lyso-phosphatidylcholine increased the lag phase of formation of conjugated double bonds induced by oxidation of the particles with copper. Incorporation of the lyse plasmalogen did not affect the maximal contents of conjugated dienes in copper oxidized LDL. Due to their relatively high concentration in LDL, their pronounced sensitivity towards oxidation and their capacity to increase the oxidative resistance of the particles, plasmalogen phospholipids may play a significant role in the defense of LDL particles against oxidative stress. (C) 1994 Academic Press, Inc.
引用
收藏
页码:1235 / 1242
页数:8
相关论文
共 16 条
[1]  
BERGELSON LD, 1980, LIPID BIOCH PREPARAT, P169
[2]  
Bligh E.G., 1959, CAN J BIOCHEM PHYSIO, V37, P912
[3]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[4]   CHANGES OF MEMBRANE PHOSPHOLIPID-COMPOSITION OF HUMAN ERYTHROCYTES IN HYPERLIPIDEMIAS .1. INCREASED PHOSPHATIDYLCHOLINE AND REDUCED SPHINGOMYELIN IN PATIENTS WITH ELEVATED LEVELS OF TRIACYLGLYCEROL-RICH LIPOPROTEINS [J].
ENGELMANN, B ;
STREICH, S ;
SCHONTHIER, UM ;
RICHTER, WO ;
DUHM, J .
BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1165 (01) :32-37
[5]   ENDOGENOUS ANTIOXIDANTS AND LIPOPROTEIN OXIDATION [J].
ESTERBAUER, H ;
DIEBERROTHENEDER, M ;
WAEG, G ;
PUHL, H ;
TATZBER, F .
BIOCHEMICAL SOCIETY TRANSACTIONS, 1990, 18 (06) :1059-1061
[6]   CONTINUOUS MONITORING OF INVITRO OXIDATION OF HUMAN LOW-DENSITY LIPOPROTEIN [J].
ESTERBAUER, H ;
STRIEGL, G ;
PUHL, H ;
ROTHENEDER, M .
FREE RADICAL RESEARCH COMMUNICATIONS, 1989, 6 (01) :67-75
[7]  
ESTERBAUER H, 1988, EICOSANOIDS LIPID PE, P203
[8]  
FREI B, 1993, J LIPID RES, V34, P2135
[9]   DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM [J].
HAVEL, RJ ;
EDER, HA ;
BRAGDON, JH .
JOURNAL OF CLINICAL INVESTIGATION, 1955, 34 (09) :1345-1353
[10]  
HORROCKS LA, 1968, J LIPID RES, V9, P469